Digital Platform for the Development of Next-Generation ADCs
Automated HT-Engineering Platform for AI-Supported Developability Predictions
Accelerating Biopharmaceutical and Vaccine Research, Discovery, and Development
NGS for CMC of Gene and Cell Therapy Products
Long-Read NGS for QC in CGTs Manufacturing
Do's and Don'ts of CSV for In-House NGS-Based Biosafety Assays
Platform for Streamlined LC/MS-based MAM Implementation
MS Analytics Platform for Emerging Therapeutic Modalities
Scalable, Automated Data Analysis Across RNA Therapeutics Assays
Data Integration Platform for Bioassays in Preclinical & Clinical Studies
Identification of Scrambled Disulfide Bonds in Biotherapeutics
GMP-Compliant NGS for Biotherapeutics Development
HT Screening for Best Manufacturing Cell Lines Using Scale-Down Models
Affinity-Based Screening Using HT Spectral Shift
Automated HT Multiplexed Intact Covalent Binding Data Analysis Workflow
Next Generation Trait Development and Crop Protection
End-to-End Assay Automation
SPR Evaluation of Large Bispecific Antibody Panels
Manage Developability & Manufacturability Risks of Biologics Molecules
AI-Based Segmentation for Single Cell Profiling
Automated Production of Viral Vectors for Cell and Gene Therapy
Genedata Selector: GMP Compliance for Safe Gene Therapy Development
ADC Therapeutics’ New ADC Workflow System
Comprehensive Antibody Discovery Screening with NGS
AI-based Denoising of LC-MS Data via Generative Adversarial Networks
MS-Based Characterization of Adeno-associated Virus Capsids
Automated and Robust Identification of Scrambled Disulfide Bonds
NGS for Monitoring CQAs of Gene Therapy Products
DNN Interpretability in HCI through Deep Feature Isolation Mixing
A Data Processing Workflow for Comprehensive Middle-down Analysis
A Fully Automated Data Workflow for Quality Monitoring of Oligonucleotide Therapeutics
Automating R&D of Viral and Non-Viral Vectors for Cell and Gene Therapies
NGS-Based Biosafety Assessment of Biologics in GMP
AI Automates SPR/BLI Binding Profile Assignment
A Single, Integrated Software Platform for LC/MS-based MAM Approaches
In-House NGS-Based CQAs Assessment of Gene Therapies
Bispecific Antibodies: HT Generation, Design, Production, Evaluation
Advancing Cell Therapies Using NGS as a Multi-Attribute Method
NGS-Based Testing of Cell Therapy Products in a Validated Environment
